Loading
Loading…
Loading…
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Finance | Admitted-Finance |
| 2 | Admitted-Finance | Admitted-Finance |
| 3 | Admitted-Finance | Admitted-Finance |
| 4 | Admitted-Finance | Admitted-Finance |
| 5 | Admitted-Finance | Admitted-Finance |
Tender Value
₹24 L
Closing Date
14 May 2024, 9:15 amClosed
CFA 172MH
CFA 172MH C/o 56 APO PIN-900364
AS PER RFP
2024_ARMY_651682_1
172/MS/608/ECHS/RE-06/2024-25
Limited
Drugs and Pharmaceutical Products
Supply
21 days
CFA 172MH
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
Exempted
17 May 2024
30 Apr 2024
14 May 2024
30 Apr 2024
14 May 2024
30 Apr 2024
30 Apr 2024 - 14 May 2024
TACROLIMUS 0.5 MG TAB
DILTIAZEM 90MG SR TAB
BROMHEXINE (2MG) + GUAIFENESIN (50MG) + MENTHOL (1MG) + TERBUTALINE (1.25MG) SYRUP
ACENOCOUMAROL 1 MG TAB
SALMETEROL (50MCG) + FLUTICASONE PROPIONATE (250MCG) [ACCUHALER 50/250]
LEVODOPA (100MG) + CARBIDOPA (25MG) TAB
PHENYTOIN SODIUM 100 MG
THYROXINE 25 MCG TAB
CLINDAMYCIN 300 MG CAP
ETOPOSIDE 50 MG CAP
OLANZAPINE 10 MG TAB
DICLOFENAC SPRAY BOTTLE OF 40 GM
GLUCO STRIP ACCUCHECK ACTIVE PACK OF 50
NEVIRAPINE 200 MG TAB
NILOTINIB 200MG TAB
INJ DICLOFENAC 25MG/ML 3ML (VOVERAN)
ED BRINZOLAMIDE + BRIMONIDINE
DICLOFENAC 50MG +PCM 500MG TAB
INJ PARACETAMOL INFUSION 10MG/ML, 100ML
MODERN MEDICAL HALL
Meddcity Pharmaceuticals
NAV BHARAT SCIENTIFIC WORKS
Naveen Pharmaceuticals
MODERN MEDICAL HALL
MANIT ENTERPRISES
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .